Detail Information of Xenobiotics-driven Alterations in 3D Complexes
| General Information of Drug Transporter (DT) | |||||
|---|---|---|---|---|---|
| DT ID | DTD0452 Transporter Info | ||||
| Gene Name | SLC6A2 | ||||
| Transporter Name | Sodium-dependent noradrenaline transporter | ||||
| Gene ID | |||||
| UniProt ID | |||||
| Xenobiotics-driven Alterations in 3D Complexes (XSV) of This DT | |||||
| Xenobiotic Name | Clomipramine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 2801 | ||||
| Docking Score | -8.336 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C19H23ClN2 | ||||
| Molecular Weight | 314.9 | ||||
| Canonical SMILES |
CN(C)CCCN1C2=CC=CC=C2CCC3=C1C=C(C=C3)Cl
|
||||
| InChI |
InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3
|
||||
| InChIKey | GDLIGKIOYRNHDA-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 5.2 | Rotatable Bond Count | 4 | |
| Hydrogen Bond Donor Count | 0 | Hydrogen Bond Acceptor Count | 2 | ||
| Xenobiotic Name | Amitifadine Drug Info | ||||
| Xenobiotic Type | Drug in Phase 3 Trial | ||||
| MOA | Inhibition | ||||
| PubChem CID | 11658655 | ||||
| Docking Score | -8.307 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C11H11Cl2N | ||||
| Molecular Weight | 228.11 | ||||
| Canonical SMILES |
C1[C@H]2[C@@]1(CNC2)C3=CC(=C(C=C3)Cl)Cl
|
||||
| InChI |
InChI=1S/C11H11Cl2N/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11/h1-3,8,14H,4-6H2/t8-,11+/m1/s1
|
||||
| InChIKey | BSMNRYCSBFHEMQ-KCJUWKMLSA-N | ||||
| Pharmaceutical Properties | Xlogp | 3 | Rotatable Bond Count | 1 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 1 | ||
| Xenobiotic Name | Amoxapine Drug Info | ||||
| Xenobiotic Type | Approved Drug | ||||
| MOA | Inhibition | ||||
| PubChem CID | 2170 | ||||
| Docking Score | -8.188 kcal/mol | ||||
| EFMDA Details | EFMDA Info | ||||
| Xenobiotic Details | |||||
| Formula | C17H16ClN3O | ||||
| Molecular Weight | 313.8 | ||||
| Canonical SMILES |
C1CN(CCN1)C2=NC3=CC=CC=C3OC4=C2C=C(C=C4)Cl
|
||||
| InChI |
InChI=1S/C17H16ClN3O/c18-12-5-6-15-13(11-12)17(21-9-7-19-8-10-21)20-14-3-1-2-4-16(14)22-15/h1-6,11,19H,7-10H2
|
||||
| InChIKey | QWGDMFLQWFTERH-UHFFFAOYSA-N | ||||
| Pharmaceutical Properties | Xlogp | 2.6 | Rotatable Bond Count | 1 | |
| Hydrogen Bond Donor Count | 1 | Hydrogen Bond Acceptor Count | 3 | ||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.